Lobbying Income
$7.3M
Filings
479
Unique Clients
29
Active Period
1999–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To designate the facility of the United States Postal Service located at 110 East Alexander Street in Three Rivers, Texas, as the "Veterans Memorial Post Office".
2010 · second_quarter · Client: EMBRY-RIDDLE AERONAUTICAL UNIVERSITY
FAA Reauthorization Bill (H.R. 915) H.R. 3371 -- Airline Safety and Pilot Training Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: H.R. 915
Airline Safety and Pilot Training Improvement Act of 2009
2010 · second_quarter · Client: EMBRY-RIDDLE AERONAUTICAL UNIVERSITY
FAA Reauthorization Bill (H.R. 915) H.R. 3371 -- Airline Safety and Pilot Training Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3371
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · second_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: HR 1298
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: HR 1427
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: HR 1548
America's Affordable Health Choices Act of 2009
2010 · second_quarter · Client: LUNDBECK, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: HR 3200
Physician Payments Sunshine Act of 2009
2010 · second_quarter · Client: LUNDBECK, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: S. 301
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · second_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: S. 525
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $20,000
Matched citations: S. 726
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · second_quarter · Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · second_quarter · Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009
Client expense: — · Firm income: $20,000
Matched citations: S. 726
Internet Gambling Regulation, Consumer Protection, and Enforcement Act
2010 · second_quarter · Client: ELOTTERY INC
H.R. 2267 Internet Gaming Regulation, Consumer Protection, and Enforcement Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2267
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · first_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: HR 1298
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: HR 1427
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: HR 1548
America's Affordable Health Choices Act of 2009
2010 · first_quarter · Client: LUNDBECK, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: HR 3200
Physician Payments Sunshine Act of 2009
2010 · first_quarter · Client: LUNDBECK, INC.
HR 3200 -- Access to and coverage of Specialty Pharmaceuticals, Removal of patient life time caps and special tiering of copayments. S. 301 Physician payments and transparency, preemption of state law. America's Heathy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: S. 301
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · first_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: S. 525
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: LUNDBECK, INC.
S. 525 and HR 1298 Drug Reimportation and impact on in-licensed and out-licensed products. HR 1427, HR 1548, S. 726 Biosimilar prescription drugs and data exclusivity.
Client expense: — · Firm income: $30,000
Matched citations: S. 726
To designate the facility of the United States Postal Service located at 110 East Alexander Street in Three Rivers, Texas, as the "Veterans Memorial Post Office".
2010 · first_quarter · Client: EMBRY-RIDDLE AERONAUTICAL UNIVERSITY
FAA Reauthorization Bill (H.R. 915) H.R. 3371 -- Airline Safety and Pilot Training Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: H.R. 915
Airline Safety and Pilot Training Improvement Act of 2009
2010 · first_quarter · Client: EMBRY-RIDDLE AERONAUTICAL UNIVERSITY
FAA Reauthorization Bill (H.R. 915) H.R. 3371 -- Airline Safety and Pilot Training Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: H.R. 3371
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1427
Pathway for Biosimilars Act
2010 · first_quarter · Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: H.R. 1548
Promoting Innovation and Access to Life-Saving Medicine Act
2010 · first_quarter · Client: MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009
Client expense: — · Firm income: $30,000
Matched citations: S. 726
Source: Senate LDA